dr. chow on the use of ceritinib in alk nsclc metastatic to the brain
Published 4 years ago • 240 plays • Length 1:48Download video MP4
Download video MP3
Similar videos
-
2:06
dr. alice t. shaw on ceritinib for frontline alk nsclc with brain metastases
-
2:44
ceritinib and brain metastases in nsclc
-
6:12
experience with ceritinib for alk nsclc
-
5:52
ceritinib and alectinib in relapsed alk nsclc
-
6:47
upfront use of ceritinib in alk nsclc
-
1:04
dr. chu discusses cns penetration of ceritinib
-
7:21
ceritinib in crizotinib-resistant nsclc
-
6:37
ascend-4: upfront ceritinib in alk-rearranged nsclc
-
1:57
dr. shaw on sequencing strategies in alk-positive nsclc
-
1:23
ascend-1 and ascend-2: ceritinib for alk-rearranged nsclc and baseline brain metastases
-
5:19
ascend-5: ceritinib for alk positive nsclc previously treated with crizotinib
-
0:52
dr. stinchcombe on the benefit of alectinib in alk nsclc
-
0:59
dr. johung on prognosis of patients with alk-rearranged nsclc and brain metastases
-
1:45
dr. shaw on using crizotinib to treat lung cancer
-
1:16
rationale for evaluating ceritinib in alk-positive patients with nsclc
-
7:02
crizotinib for alk-rearranged nsclc
-
1:07
dr. subbiah on the fda approval of pralsetinib in ret nsclc
-
5:31
fda approval: frontline ceritinib for alk nsclc
-
5:21
ceritinib alternative dosing for alk nsclc